Nanjing Hongjing Pharmaceutical Technology

Nanjing Hongjing Pharmaceutical Technology is a China-based Contract Research Organization (CRO) specializing in pharmaceutical R&D and technical services. Founded in 2010 and located in the Nanjing Life Science Park, the company provides comprehensive solutions for small molecule drug development, including chemical synthesis, process optimization, and formulation research. They support both the development of high-end generic drugs and the discovery of innovative new chemical entities. Their service portfolio covers the entire R&D chain from laboratory-scale synthesis to pilot-scale production and regulatory filing. The company is recognized as a National High-tech Enterprise, serving a diverse client base in therapeutic areas such as oncology and cardiovascular medicine.